Search results
Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000–17: a financial modelling study
We aimed to generate estimates of funding for immunisation disaggregated by the source of funding and the type of activities in order to highlight the funding landscape for immunisation and inform policy making.
Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
We aimed to analyse data on the number of deaths, years of life lost, and mortality rates by sex and age group in people aged 10–24 years in 204 countries and territories from 1950 to 2019 by use of estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.
Healthcare spending in U.S. emergency departments by health condition, 2006–2016
This study’s objective is to estimate ED spending trends in the U.S. from 2006 to 2016, by age, sex, payer, and across 154 health conditions and assess ED spending per visit over time.
Anemia
Explore trends in global prevalence of anemia in women of reproductive age from 2000 to 2019.
Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
Here we map annual 2000–2018 geospatial estimates of anemia prevalence in women of reproductive age (15–49 years) across 82 low- and middle-income countries (LMICs), stratify anemia by severity and aggregate results to policy-relevant administrative and national levels.
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
In this study, we sought to quantify the impact of the COVID-19 pandemic on the prevalence and burden of depressive and anxiety disorders globally in 2020.
The COVID-19 pandemic has had a large and uneven impact on global mental health
Cases of mental disorders rose sharply during the pandemic, particularly among young women.
Fatal police violence by race and state in the USA, 1980-2019: a network meta-regression
This study examines the presence and extent of under-reporting of police violence in US Government-run vital registration data, offers a method for correcting under-reporting in these datasets, and presents revised estimates of deaths due to police violence in the USA.
Ambient and household PM2.5 pollution and adverse perinatal outcomes: A meta- regression and analysis of attributable global burden for 204 countries and territories
We estimated the global burden of low birth weight (LBW) and preterm birth (PTB) and impacts on reduced birth weight and gestational age (GA), attributable to ambient and household PM2.5 pollution in 2019.
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019
This study assesses the current sex-specific HIV burden in 204 countries and territories and measures progress in the control of the epidemic.
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019
We aimed to assess the levels and trends of the global burden of tuberculosis, with an emphasis on investigating differences in sex by HIV status for 204 countries and territories from 1990 to 2019.
Financing Global Health 2020: The Impact of COVID-19
This edition of IHME's annual Financing Global Health report, the 12th in the series, provides updated estimates of spending on health, development assistance for health, and projections of future health spending.
Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050
We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020.
FGH 2020: COVID-19
Global health financing profile of 2020 spending on COVID-19.
FGH 2020: HIV/AIDS
Global health financing profile of spending on HIV/AIDS from 1990 to 2020.
FGH 2020: Malaria
Global health financing profile of spending on malaria from 1990 to 2020.
FGH 2020: Non-communicable diseases
Global health financing profile of spending on non-communicable diseases from 1990 to 2020.
FGH 2020: Other infectious diseases
Global health financing profile of spending on other infectious diseases from 1990 to 2020.
FGH 2020: Reproductive, maternal, newborn, and child health
Global health financing profile of spending on reproductive, maternal, newborn, and child health from 1990 to 2020.
FGH 2020: Tuberculosis
Global health financing profile of spending on tuberculosis from 1990 to 2020.
Accounting for misclassified and unknown cause of death data in vital registration systems for estimating trends in HIV mortality
In this study, we describe the methods developed by the Global Burden of Disease Study to account for the misclassified cause of death data from vital registration systems for estimating HIV mortality in 132 countries and territories.